Back

Finerenone in patients with chronic kidney disease and type 2 diabetes, with and without a history of heart failure: a secondary analysis of the FIDELIO-DKD trial

29 June 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Late-Breaking Trials 1 Clinical HFA Premium Access Heart Failure 2021

About the speaker

Photo
Professor Gerasimos Filippatos

National & Kapodistrian University of Athens Medical School, Athens (Greece)

2 More presentations in this session

Presentation thumbnail
The effect of intravenous ferric-carboxymaltose on cardiac reverse remodeling following cardiac resynchronization therapy - The IRON CRT trial.
Professor P. Martens (Genk, BE)
Slides Video
Presentation thumbnail
Influence of Atrial Fibrillation on Efficacy of Omecamtiv Mecarbil in Heart Failure: The GALACTIC-HF Trial
Professor S. Solomon (Boston, US)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Trials 1
Video

The Event

Event poster

Heart Failure 2021

29 June - 1 July 2021
You may be interested in
thumbnail
Congress Session
Acute heart failure: what to watch for
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Webinar
Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources